Jennifer Dent

Jennifer oversees BVGH’s strategy, programs, and partnerships. She establishes public-private partnerships through international industry experience to tackle global health challenges with sustainability, scalability, and priorities set by low- and middle-income country partners. Jennifer’s 25+ years of pharmaceutical and biotechnology experience includes negotiation, global discovery management, and alliances. Jennifer began her career in various positions for Parke Davis/Pfizer and Genentech. Following Roche’s acquisition of Genentech Canada, she held senior management positions in global product strategy, business development, and alliance management for multiple countries. Jennifer co-founded Sound Biotechnology after serving as Vice President, Business Development, Marketing, and Sales at CombiMatrix Corporation.